Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Bullboard Posts
Comment by georgesoreloseon Jun 06, 2017 12:08pm
85 Views
Post# 26330055

RE:More pressure to "produce" ??

RE:More pressure to "produce" ??cut and paster is "brokeneded"...

KEY words tho...CONGRATS to CTSO et al !!!!!!!!!!!!!!!!!!!!!!!!!!!!

"We are delighted to be engaged with CytoSorbents to help create a comprehensive and impactful investor relations program," said Michael Rice, founder of LifeSci Partners. "The company has been successful in getting its CytoSorb blood purification technology onto the market in Europe, sales are on a positive growth trajectory, and there is a clear path to FDA approval in the U.S.  As with all LifeSci Partners clients, we see this relationship as a partnership, and we look forward to collaborating with Dr. Phillip Chan and his team to raise the company's profile and attract new institutional and retail investors."
Bullboard Posts